Evolutionary divergence of the necroptosis effector MLKL

Cell Death and Differentiation

Volumn 23, Issue 7, 2016, Pages 1185-1197

  Tanzer, M C ^a,b   Matti, I ^a,b   Hildebrand, J M ^a,b   Young, S N ^a   Wardak, A ^a   Tripaydonis, A ^a,b   Petrie, E J ^a,b   Mildenhall, A L ^a,b   Vaux, D L ^a,b   Vince, J E ^a,b   Czabotar, P E ^a,b   Silke, J ^a,b   Murphy, J M ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; MIXED LINEAGE KINASE DOMAIN LIKE PROTEIN; PROTEIN SERINE THREONINE KINASE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; MLKL PROTEIN, HUMAN; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECOMBINANT PROTEIN; RIPK3 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DIMERIZATION; DOMESTIC HORSE; EVOLUTION; FEMALE; FOUR HELIX BUNDLE; GASTEROSTEUS ACULEATUS; HUMAN; HUMAN CELL; MOUSE; MUS MUSCULUS; NECROPTOSIS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; XENOPUS LAEVIS; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CHICKEN; DRUG EFFECTS; GENETICS; HELA CELL LINE; HORSE; HT-29 CELL LINE; METABOLISM; MOLECULAR EVOLUTION; NECROSIS; PHOSPHORYLATION; PROTEIN DOMAIN;

ANIMALS; APOPTOSIS; CELL LINE; CELL MEMBRANE PERMEABILITY; CHICKENS; EVOLUTION, MOLECULAR; HELA CELLS; HORSES; HT29 CELLS; HUMANS; LIPOSOMES; MICE; NECROSIS; PHOSPHORYLATION; PROTEIN DOMAINS; PROTEIN KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECOMBINANT PROTEINS;

EID: 84957922797     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.169     Document Type: Article

References (32)

1. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009; 137: 1112-1123.
2. He S, Wang L, Miao L, Wang T, Du F, Zhao L et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137: 1100-1111.
3. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 1: 489-495.
4. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008; 4: 313-321.
5. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013; 39: 443-453.
6. Sun L, Wang H, Wang Z, He S, Chen S, Liao D et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012; 148: 213-227.
7. Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA 2012; 109: 5322-5327.
8. Wu J, Huang Z, Ren J, Zhang Z, He P, Li Y et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res 2013; 23: 994-1006.
9. Czabotar PE, Murphy JM. A tale of two domains-a structural perspective of the pseudokinase, MLKL. FEBS J 2015; 282: 4268-4278.
10. Hildebrand JM, Tanzer MC, Lucet IS, Young SN, Spall SK, Sharma P et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci USA 2014; 111: 15072-15077.
11. Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 2014; 16: 55-65.
12. Chen X, Li W, Ren J, Huang D, He WT, Song Y et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 2014; 24: 105-121.
13. Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 2014; 7: 971-981.
14. Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 2014; 54: 133-146.
15. Tanzer MC, Tripaydonis A, Webb AI, Young SN, Varghese LN, Hall C et al. Necroptosis signalling is tuned by phosphorylation of MLKL residues outside the pseudokinase domain activation loop. Biochem J 2015; 471: 255-265.
16. Linkermann A, Green DR. Necroptosis. N Engl J Med 2014; 370: 455-465.
17. Rodriguez DA, Weinlich R, Brown S, Guy C, Fitzgerald P, Dillon CP et al. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell Death Differ 2016; 23: 76-88.
18. Su L, Quade B, Wang H, Sun L, Wang X, Rizo J. A plug release mechanism for membrane permeation by MLKL. Structure 2014; 22: 1489-1500.
19. Yoon S, Bogdanov K, Kovalenko A, Wallach D. Necroptosis is preceded by nuclear translocation of the signaling proteins that induce it. Cell Death Differ (e-pub ahead of print 17 July 2015; doi:10.1038/cdd.2015.92).
20. Tait SW, Oberst A, Quarato G, Milasta S, Haller M, Wang R et al. Widespread mitochondrial depletion via mitophagy does not compromise necroptosis. Cell Rep 2013; 5: 878-885.
21. Cook WD, Moujalled DM, Ralph TJ, Lock P, Young SN, Murphy JM et al. RIPK1-and RIPK3-induced cell death mode is determined by target availability. Cell Death Differ 2014; 21: 1600-1612.
22. Chen W, Zhou Z, Li L, Zhong CQ, Zheng X, Wu X et al. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J Biol Chem 2013; 288: 16247-16261.
23. Jacobsen AV, Lowes KN, Tanzer MC, Lucet IS, Hildebrand JM, Petrie EJ et al. HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death. Cell Death Dis 2016; 7: e2051.
24. Lawlor KE, Khan N, Mildenhall A, Gerlic M, Croker BA, D'Cruz AA et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat Commun 2015; 6: 6282.
25. Murphy JM, Vince JE. Post-translational control of RIPK3 and MLKL mediated necroptotic cell death. F1000Res 2015; 4: 1297.
26. Moujalled DM, Cook WD, Murphy JM, Vaux DL. Necroptosis induced by RIPK3 requires MLKL but not Drp1. Cell Death Dis 2014; 5: e1086.
27. Remijsen Q, Goossens V, Grootjans S, Van den Haute C, Vanlangenakker N, Dondelinger Y et al. Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis. Cell Death Dis 2014; 5: e1004.
28. Schenk B, Fulda S. Reactive oxygen species regulate Smac mimetic/TNFalpha-induced necroptotic signaling and cell death. Oncogene 2015; 34: 5796-5806.
29. Murphy JM, Lucet IS, Hildebrand JM, Tanzer MC, Young SN, Sharma P et al. Insights into the evolution of divergent nucleotide-binding mechanisms among pseudokinases revealed by crystal structures of human and mouse MLKL. Biochem J 2014; 457: 369-377.
30. Murphy JM, Zhang Q, Young SN, Reese ML, Bailey FP, Eyers PA et al. A robust methodology to subclassify pseudokinases based on their nucleotide binding properties. Biochem J 2014; 457: 323-334.
31. Fridriksson EK, Shipkova PA, Sheets ED, Holowka D, Baird B, McLafferty FW. Quantitative analysis of phospholipids in functionally important membrane domains from RBL-2H3 mast cells using tandem high-resolution mass spectrometry. Biochemistry 1999; 38: 8056-8063.
32. Xu C, Gagnon E, Call ME, Schnell JR, Schwieters CD, Carman CV et al. Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosinebased motif. Cell 2008; 135: 702-713.